Xylem stock is trading -16.46% below its average target price of $146.13 after marking a 1.0% during today's afternoon session. Analysts are giving the Large-Cap Fluid Controls company an average rating of buy and target prices ranging from $114.15 to $174.0 per share.
The stock has a very low short interest at 1.8%, and a short ratio of 2.22. The company's insiders own 0.66% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 96.7% of Xylem's shares being owned by this investor type.
Institutions Invested in Xylem
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2024-12-31 | Vanguard Group Inc | 12% | 28,644,417 | $3,496,767,117 |
| 2024-12-31 | Blackrock Inc. | 10% | 25,115,963 | $3,066,031,106 |
| 2024-12-31 | State Street Corporation | 4% | 10,815,771 | $1,320,335,211 |
| 2024-12-31 | Aristotle Capital Management, LLC | 3% | 8,271,667 | $1,009,763,723 |
| 2024-12-31 | Geode Capital Management, LLC | 2% | 5,804,247 | $708,553,434 |
| 2024-12-31 | Impax Asset Management Group plc | 2% | 5,561,661 | $678,939,749 |
| 2024-12-31 | Amundi | 2% | 5,343,067 | $652,254,887 |
| 2024-12-31 | Pictet Asset Management Holding SA | 2% | 5,355,809 | $653,810,367 |
| 2024-12-31 | Morgan Stanley | 2% | 4,660,116 | $568,883,646 |
| 2024-12-31 | Royal Bank of Canada | 2% | 4,369,804 | $533,443,809 |
Besides an analyst consensus of some upside potential, other market factors point to there being mixed market sentiment on Xylem.
